Drug intelligence / Profile preview

ticagrelor + morphine + metoclopramide

Development stage: Preclinical
Lead developer: AstraZeneca
Modality: Small Molecules
Administration: Oral, Intravenous

Overview

This is a combination of three medications used in acute coronary syndrome patients. Ticagrelor is an oral P2Y12 inhibitor antiplatelet medication, morphine is an opioid analgesic, and metoclopramide is a prokinetic agent. The combination addresses the known interaction between morphine and ticagrelor, where morphine delays the absorption and onset of action of ticagrelor. Metoclopramide is co-administered to overcome this delay by increasing gastric emptying and improving the pharmacokinetics and pharmacodynamics of ticagrelor.

Targets

VIPR1 (Vasoactive intestinal peptide receptor 1)HTR4 (5-Hydroxytryptamine receptor 4)HTR3A (5-hydroxytryptamine receptor 3A)VIPR2 (Vasoactive intestinal polypeptide receptor 2)MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)P2Y12 (Purinergic P2Y12 receptor)KOR (Kappa opioid receptor)DRD2 (Dopamine D2 Receptor)ADCYAP1R1 (Pituitary adenylate cyclase-activating polypeptide receptor PAC1)ENT1 (Solute carrier family 29 member 1)

Beyond the preview

Go deeper on ticagrelor + morphine + metoclopramide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ticagrelor + morphine + metoclopramide.

Explore the full profile